Project Grant R01DK145499
- Federal Grant Award Summary Northwestern University received a $731,850 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 5, 2025, with a completion date of May 31, 2029. The research project, titled "Bioenergetics of Time-Restricted Feeding Within the Brain-Adipose Axis," will advance fundamental scientific understanding of how...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Illinois a $295,494 Project Grant on September 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant funds the ACCELERATED-T2D research initiative, which investigates disparities in treatment intensification patterns across socioeconomic status backgrounds in Type 2 Diabetes patients. The project...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded New York University School of Medicine a $158,943 Project Grant on July 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This five-year initiative, scheduled for completion by May 31, 2030, develops and tests a community health worker (CHW)-led intervention designed to support South Asian patients with Type 2 Diabetes who are at...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Pittsburgh a $664,240 Project Grant on March 18, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This award supports basic biomedical research investigating the epigenetic regulation of hypothalamic energy homeostasis and its role in controlling body weight and food intake. The research focuses on...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the Regents of the University of Michigan a $779,978 Project Grant on September 6, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This research initiative, titled "Improving Diabetes Outcomes and Health Disparities by Addressing Unmet Resource Needs," will develop and test adaptive intervention sequences to address...
- Federal Grant Award Summary The University of Florida's Division of Sponsored Research received a $663,104 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective February 2, 2026, through January 31, 2031. This research initiative will investigate the renal and adrenal actions of the Period 1 (PER1) clock protein in salt-sensitive hypertension....
- Federal Project Grant Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Illinois a $824,655 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on July 1, 2025, with completion scheduled for April 30, 2030. The research will be conducted at the University of Illinois Chicago campus and focuses on elucidating the protective mechanisms of growth hormone (GH) and signal transducer and...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Pittsburgh a $343,954 Project Grant on September 13, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct a pilot intervention study addressing health-related social needs (HRSN) in adolescents and young adults with Type 2 Diabetes (T2D). The project, titled ONWARD (Optimizing Navigation for Wellness and...
- Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $847,068 Project Grant to the University of Missouri at Kansas City on March 10, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The project, scheduled for completion by February 28, 2031, addresses food access and physical activity interventions to improve diabetes prevention outcomes among underserved African Americans. The research will...
- Federal Project Grant Award Summary Rush University Medical Center received a $942,000 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, effective September 16, 2025, through August 31, 2028, funds a feasibility study to develop and evaluate a primary care-based weight management intervention program for patients discontinuing anti-obesity...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $516,468 to the University of Illinois on March 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct research on physical activity (PA) timing in relation to glycemic control among night workers versus day workers. The five-year project, concluding February 28, 2031, will recruit 400 non-diabetic participants (200 night workers and 200 day workers) from transportation, healthcare, manufacturing, retail, and leisure/hospitality industries in the Chicago metropolitan area. Participants will wear continuous glucose monitors and PA monitors for two weeks while providing information on work schedules, meal and sleep timing, and perceived barriers and facilitators to PA at different times of day. The research will deliver comparative analysis of timing-related activity profiles between night and day workers, examining when participants are most active, how PA bouts align with daily events such as meals and sleep, and the day-to-day regularity of PA habits. The project aims to determine whether the optimal timing window for PA to improve glycemic control differs between night workers and day workers, potentially challenging current evidence-based recommendations that suggest the ideal time window is one hour before bed. This research addresses a significant public health gap, as approximately 11 million Americans engage in frequent night work, which correlates with impaired glycemic control, yet night workers remain underrepresented in existing PA timing studies.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $516.5k | 3/9/26 |